Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Preemptive Nebulized Dexamethasone in Reducing Post- Operative Sore Throat Following the Use of AMBU® AURAGAINTM Device: A Double Blind, Randomised Clinical Trial

NCT04771026 is registered in ClinicalTrials.gov with Universiti Sains Malaysia as lead sponsor.

NCT NCT04771026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04771026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Preemptive Nebulized Dexamethasone in Reducing Post- Operative Sore Throat Following the Use of AMBU® AURAGAINTM Device: A Double Blind, Randomised Clinical Trial
Lead sponsor
Universiti Sains Malaysia
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2020
Completion date
December 31, 2021
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexamethasone, hoarseness, sore throat, supraglottic airway devices